{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:09:35Z","timestamp":1775790575954,"version":"3.50.1"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.neuropharm.2018.09.017","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T04:18:47Z","timestamp":1537417127000},"page":"130-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The 5-HT3 receptor antagonist ondansetron potentiates the effects of the acetylcholinesterase inhibitor donepezil on neuronal network oscillations in the rat dorsal hippocampus"],"prefix":"10.1016","volume":"143","author":[{"given":"Katrine","family":"Skovg\u00e5rd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Agerskov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0183-3816","authenticated-orcid":false,"given":"Kristi A.","family":"Kohlmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-0394","authenticated-orcid":false,"given":"Kjartan F.","family":"Herrik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.09.017_bib1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neuropharm.2014.08.015","article-title":"Cortical EEG oscillations and network connectivity as efficacy indices for assessing drugs with cognition enhancing potential","volume":"86","author":"Ahnaou","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1471-4159.1984.tb00913.x","article-title":"Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia","volume":"43","author":"Arai","year":"1984","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1017\/S1461145710000659","article-title":"Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats","volume":"13","author":"Arnt","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuroimage.2003.09.028","article-title":"Mapping distributed sources of cortical rhythms in mild Alzheimer's disease. A multicentric EEG study","volume":"22","author":"Babiloni","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.clinph.2012.09.017","article-title":"Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients","volume":"124","author":"Babiloni","year":"2013","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00692056","article-title":"Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia","volume":"37","author":"Ball","year":"1977","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.neuropharm.2008.08.003","article-title":"The 5-HT3 receptor - the relationship between structure and function","volume":"56","author":"Barnes","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib8","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/B978-0-7020-5307-8.00002-8","article-title":"Brain's alpha, beta, gamma, delta, and theta oscillations in neuropsychiatric diseases: proposal for biomarker strategies","volume":"62","author":"Basar","year":"2013","journal-title":"Suppl. Clin. neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pbb.2015.02.011","article-title":"A 5-HT3 receptor antagonist potentiates the behavioral, neurochemical and electrophysiological actions of an SSRI antidepressant","volume":"131","author":"Betry","year":"2015","journal-title":"Pharmacol., Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib11","article-title":"Donepezil for dementia due to Alzheimer's disease","volume":"1","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0149-7634(97)00013-4","article-title":"Anatomical, electrophysiological and pharmacological studies of ascending brainstem hippocampal synchronizing pathways","volume":"22","author":"Bland","year":"1998","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1023\/A:1022486705184","article-title":"The central 5-HT3 receptor in CNS disorders","volume":"23","author":"Bloom","year":"1998","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib14","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1046\/j.1471-4159.1995.64031401.x","article-title":"Ultrastructure of the 5-hydroxytryptamine3 receptor","volume":"64","author":"Boess","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib15","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.1523\/JNEUROSCI.1413-04.2004","article-title":"Phase segregation of medial septal GABAergic neurons during hippocampal theta activity","volume":"24","author":"Borhegyi","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1471-4159.1983.tb11838.x","article-title":"Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease","volume":"41","author":"Bowen","year":"1983","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1476-5381.1988.tb11542.x","article-title":"Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors","volume":"94","author":"Butler","year":"1988","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0896-6273(02)00586-X","article-title":"Theta oscillations in the hippocampus","volume":"33","author":"Buzsaki","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0896-6273(02)00586-X","article-title":"Theta oscillations in the Hippocampus","volume":"33","author":"Buzs\u00e1ki","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib20","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1126\/science.1099745","article-title":"Neuronal oscillations in cortical networks","volume":"304","author":"Buzsaki","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-4328(97)80988-6","article-title":"Dose-related impairment of spatial learning by intrahippocampal scopolamine: antagonism by ondansetron, a 5-HT3 receptor antagonist","volume":"82","author":"Carli","year":"1997","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00441-006-0255-8","article-title":"Serotonin 5-HT(3) receptors in the central nervous system","volume":"326","author":"Chameau","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib23","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1021\/acschemneuro.5b00135","article-title":"Serotonin: a new hope in Alzheimer's disease?","volume":"6","author":"Claeysen","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0197-4580(00)00183-4","article-title":"Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis","volume":"21","author":"Cummings","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib25","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer's disease","volume":"308","author":"Davies","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-385902-0.00001-2","article-title":"The central role of 5-HT6 receptors in modulating brain neurochemistry","volume":"96","author":"Dawson","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0006-8993(02)03483-2","article-title":"GABA(A) receptor antagonists enhance cortical acetylcholine release induced by 5-HT(3) receptor blockade in freely moving rats","volume":"956","author":"Diez-Ariza","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000357026","article-title":"Coordinated network activity in the hippocampus","volume":"34","author":"Draguhn","year":"2014","journal-title":"Front Neurol Neurosci"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2007.01.028","article-title":"The neuronal 5-HT3 receptor network after 20 years of research--evolving concepts in management of pain and inflammation","volume":"560","author":"Faerber","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/(SICI)1098-1063(2000)10:2<187::AID-HIPO8>3.0.CO;2-M","article-title":"Cholinergic induction of oscillations in the hippocampal slice in the slow (0.5-2 Hz), theta (5-12 Hz), and gamma (35-70 Hz) bands","volume":"10","author":"Fellous","year":"2000","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0165-0173(82)90011-X","article-title":"The organization and some projections of cholinergic neurons of the mammalian forebrain","volume":"257","author":"Fibiger","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/336170a0","article-title":"GABA-containing neurons in the septum control inhibitory interneurons in the hippocampus","volume":"336","author":"Freund","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/cne.902390210","article-title":"Cholinergic innervation of the rat hippocampus as revealed by choline acetyltransferase immunocytochemistry: a combined light and electron microscopic study","volume":"239","author":"Frotscher","year":"1985","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fnagi.2018.00101","article-title":"Theta-gamma coupling and working memory in Alzheimer's dementia and mild cognitive impairment","volume":"10","author":"Goodman","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib35","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.neuropharm.2012.01.014","article-title":"Memantine potentiates hippocampal theta oscillations at a therapeutic dose in anesthetized mice: a mechanistic link to its cognitive-enhancing properties","volume":"62","author":"Guadagna","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib36","doi-asserted-by":"crossref","first-page":"8094","DOI":"10.1523\/JNEUROSCI.5665-08.2009","article-title":"GABAergic neurons of the medial septum lead the hippocampal network during theta activity","volume":"29","author":"Hangya","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib39","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.neuroscience.2015.09.064","article-title":"Distribution of serotonin receptor 5-HT6 mRNA in rat neuronal subpopulations: a double in situ hybridization study","volume":"310","author":"Helboe","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.neuropharm.2016.03.043","article-title":"The 5-HT6 receptor antagonist idalopirdine potentiates the effects of acetylcholinesterase inhibition on neuronal network oscillations and extracellular acetylcholine levels in the rat dorsal hippocampus","volume":"107","author":"Herrik","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib41","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00213-013-3373-5","article-title":"The alpha-7 nicotinic receptor partial agonist\/5-HT3 antagonist RG3487 enhances cortical and hippocampal dopamine and acetylcholine release","volume":"231","author":"Huang","year":"2014","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib42","first-page":"576","article-title":"5-HT3a receptors modulate hippocampal gamma oscillations by regulating synchrony of parvalbumin-positive interneurons","volume":"26","author":"Huang","year":"2016","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib43","doi-asserted-by":"crossref","first-page":"12521","DOI":"10.1523\/JNEUROSCI.0640-09.2009","article-title":"Gamma-band synchronization in the macaque hippocampus and memory formation","volume":"29","author":"Jutras","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib44","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1523\/JNEUROSCI.5264-08.2009","article-title":"Synaptic cross talk between perisomatic-targeting interneuron classes expressing cholecystokinin and parvalbumin in hippocampus","volume":"29","author":"Karson","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib45","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1460-9568.1998.00026.x","article-title":"The rhythmicity of cells of the medial septum\/diagonal band of Broca in the awake freely moving rat: relationships with behaviour and hippocampal theta","volume":"10","author":"King","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(24)35076-1","article-title":"Cognition-enhancing drugs increase stimulated hippocampal theta rhythm amplitude in the urethane-anesthetized rat","volume":"291","author":"Kinney","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib47","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0361-9230(02)00827-4","article-title":"Depth amplitude and phase profiles of carbachol-induced theta in hippocampal formation slices","volume":"58","author":"Kowalczyk","year":"2002","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib48","doi-asserted-by":"crossref","first-page":"42884","DOI":"10.1038\/srep42884","article-title":"Building a 5-HT3A receptor expression map in the mouse brain","volume":"7","author":"Koyama","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib49","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0306-4522(94)90341-7","article-title":"Hippocampal theta activity following selective lesion of the septal cholinergic system","volume":"62","author":"Lee","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib50","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1021\/cn500340j","article-title":"Serotonergic regulation of prefrontal cortical circuitries involved in cognitive processing: a review of individual 5-HT receptor mechanisms and concerted effects of 5-HT receptors exemplified by the multimodal antidepressant vortioxetine","volume":"6","author":"Leiser","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib51","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1126\/science.7878473","article-title":"Storage of 7 +\/- 2 short-term memories in oscillatory subcycles","volume":"267","author":"Lisman","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib52","doi-asserted-by":"crossref","first-page":"P901","DOI":"10.1016\/j.jalz.2015.08.132","article-title":"RVT-101, a 5-ht6 receptor antagonist, as adjunctive therapy with donepezil in adults with mild-to-moderate Alzheimer's disease: responder analysis","volume":"11","author":"Lombardo","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib53","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1021\/cn300184t","article-title":"Activation of 5-HT6 receptors modulates sleep-wake activity and hippocampal theta oscillation","volume":"4","author":"Ly","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib54","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1152\/physrev.1995.75.4.835","article-title":"Role of microtubule-associated proteins in the control of microtubule assembly","volume":"75","author":"Maccioni","year":"1995","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib55","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.arcmed.2010.03.007","article-title":"The revitalized tau hypothesis on Alzheimer's disease","volume":"41","author":"Maccioni","year":"2010","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib56","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/gps.2562","article-title":"SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study","volume":"26","author":"Maher-Edwards","year":"2011","journal-title":"Int. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib57","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/FBP.0b013e3282ee82e3","article-title":"Elicited hippocampal theta rhythm: a screen for anxiolytic and procognitive drugs through changes in hippocampal function?","volume":"18","author":"McNaughton","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib58","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1515\/revneuro-2013-0026","article-title":"5-HT systems: emergent targets for memory formation and memory alterations","volume":"24","author":"Meneses","year":"2013","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib59","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1515\/revneuro-2012-0060","article-title":"Serotonin and emotion, learning and memory","volume":"23","author":"Meneses","year":"2012","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib60","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0306-4522(83)90108-2","article-title":"Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1\u2013Ch6)","volume":"10","author":"Mesulam","year":"1983","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib61","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1523\/JNEUROSCI.17-09-03157.1997","article-title":"The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon","volume":"17","author":"Morales","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2017.02.010","article-title":"Effects of the 5-HT6 receptor antagonist idalopirdine on extracellular levels of monoamines, glutamate and acetylcholine in the rat medial prefrontal cortex","volume":"799","author":"M\u00f8rk","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib63","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neubiorev.2009.12.014","article-title":"Functional role of gamma and theta oscillations in episodic memory","volume":"34","author":"Nyhus","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib64","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib65","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1113\/jphysiol.2013.263889","article-title":"Transition between fast and slow gamma modes in rat hippocampus area CA1 in vitro is modulated by slow CA3 gamma oscillations","volume":"592","author":"Pietersen","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib66","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1523\/JNEUROSCI.21-09-03175.2001","article-title":"Gating of human theta oscillations by a working memory task","volume":"21","author":"Raghavachari","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/alzrt169","article-title":"5-HT6 receptors and Alzheimer's disease","volume":"5","author":"Ramirez","year":"2013","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib68","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40265-014-0217-5","article-title":"Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status","volume":"74","author":"Ramirez","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib69","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1152\/jn.1997.77.1.517","article-title":"Effects of 5-HT3 receptor antagonism on hippocampal cellular activity in the freely moving rat","volume":"77","author":"Reznic","year":"1997","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib70","doi-asserted-by":"crossref","first-page":"11037","DOI":"10.1073\/pnas.88.24.11037","article-title":"Magnetic field tomography of coherent thalamocortical 40-Hz oscillations in humans","volume":"88","author":"Ribary","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib71","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S1388-2457(99)00123-6","article-title":"EEG spectral profile to stage Alzheimer's disease","volume":"110","author":"Rodriguez","year":"1999","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib72","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1212\/WNL.50.1.136","article-title":"A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease","volume":"50","author":"Rogers","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib73","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/sj.npp.1301503","article-title":"Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466","volume":"33","author":"Schechter","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib74","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/cercor\/bhl030","article-title":"Hippocampal and neocortical gamma oscillations predict memory formation in humans","volume":"17","author":"Sederberg","year":"2007","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib75","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1460-9568.2005.04560.x","article-title":"Activation of \u03b17 acetylcholine receptors augments stimulation-induced hippocampal theta oscillation","volume":"23","author":"Siok","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib76","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.neuropharm.2008.09.013","article-title":"Anxiolytic profile of pregabalin on elicited hippocampal theta oscillation","volume":"56","author":"Siok","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib77","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.neuron.2008.09.014","article-title":"Entrainment of neocortical neurons and gamma oscillations by the hippocampal theta rhythm","volume":"60","author":"Sirota","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib78","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1126\/science.271.5257.1870","article-title":"Replay of neuronal firing sequences in rat hippocampus during sleep following spatial experience","volume":"271","author":"Skaggs","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib79","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1113\/jphysiol.2003.046847","article-title":"Distinct electrophysiological properties of glutamatergic, cholinergic and GABAergic rat septohippocampal neurons: novel implications for hippocampal rhythmicity","volume":"551","author":"Sotty","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib80","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.neuropharm.2010.06.005","article-title":"Investigation into the efficacy of the acetylcholinesterase inhibitor, donepezil, and novel procognitive agents to induce gamma oscillations in rat hippocampal slices","volume":"59","author":"Spencer","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib81","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00004691-200212000-00010","article-title":"Generalized synchronization of MEG recordings in Alzheimer's Disease: evidence for involvement of the gamma band","volume":"19","author":"Stam","year":"2002","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib82","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1523\/JNEUROSCI.15-03-02445.1995","article-title":"Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat","volume":"15","author":"Staubli","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib83","doi-asserted-by":"crossref","DOI":"10.1093\/cercor\/bhy140","article-title":"Altered cortical and hippocampal excitability in TgF344-AD rats modeling Alzheimer's disease pathology","author":"Stoiljkovic","year":"2018","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib84","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-132690","article-title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"41","author":"Tan","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib85","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1073\/pnas.90.4.1430","article-title":"Nervous system distribution of the serotonin 5-HT3 receptor mRNA","volume":"90","author":"Tecott","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib86","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1152\/jn.00106.2010","article-title":"Measuring phase-amplitude coupling between neuronal oscillations of different frequencies","volume":"104","author":"Tort","year":"2010","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib87","doi-asserted-by":"crossref","first-page":"20942","DOI":"10.1073\/pnas.0911331106","article-title":"Theta-gamma coupling increases during the learning of item-context associations","volume":"106","author":"Tort","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 2","key":"10.1016\/j.neuropharm.2018.09.017_bib88","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1113\/jphysiol.1997.sp022033","article-title":"Disinhibition of rat hippocampal pyramidal cells by GABAergic afferents from the septum","volume":"500","author":"Toth","year":"1997","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib89","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1586\/ern.09.23","article-title":"Donepezil in the treatment of patients with Alzheimer's disease","volume":"9","author":"Tsuno","year":"2009","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib90","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuroscience.2004.08.020","article-title":"Calcium influx through presynaptic 5-HT3 receptors facilitates GABA release in the hippocampus: in vitro slice and synaptosome studies","volume":"129","author":"Turner","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib91","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.nurt.2008.05.008","article-title":"5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease","volume":"5","author":"Upton","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib92","doi-asserted-by":"crossref","first-page":"13535","DOI":"10.1073\/pnas.1411233111","article-title":"Optogenetic activation of septal cholinergic neurons suppresses sharp wave ripples and enhances theta oscillations in the hippocampus","volume":"111","author":"Vandecasteele","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib93","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/35067550","article-title":"The brainweb: phase synchronization and large-scale integration","volume":"2","author":"Varela","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib94","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0301-0082(82)90005-3","article-title":"Brain stem generation of the hippocampal EEG","volume":"19","author":"Vertes","year":"1982","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib95","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0306-4522(88)90077-2","article-title":"Brainstem afferents to the basal forebrain in the rat","volume":"24","author":"Vertes","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib96","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","article-title":"Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain","volume":"215","author":"Whitehouse","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.09.017_bib97","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S1474-4422(14)70198-X","article-title":"Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial","volume":"13","author":"Wilkinson","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2018.09.017_bib98","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jpba.2007.02.024","article-title":"Development of a liquid chromatography\/tandem mass spectrometry method for the quantitation of acetylcholine and related neurotransmitters in brain microdialysis samples","volume":"44","author":"Zhang","year":"2007","journal-title":"J. Pharmaceut. Biomed. Anal."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818306555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818306555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T23:00:17Z","timestamp":1751929217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818306555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":98,"alternative-id":["S0028390818306555"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.017","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 5-HT3 receptor antagonist ondansetron potentiates the effects of the acetylcholinesterase inhibitor donepezil on neuronal network oscillations in the rat dorsal hippocampus","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}